Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of HB05P Supplementation on Muscle Strength Improvement: A Randomized, Double-blind, Controlled Preliminary Clinical Trial (HB05P-Muscle Trial)

NCT07749118 is registered in ClinicalTrials.gov with Pusan National University Yangsan Hospital as lead sponsor.

NCT NCT07749118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07749118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of HB05P Supplementation on Muscle Strength Improvement: A Randomized, Double-blind, Controlled Preliminary Clinical Trial (HB05P-Muscle Trial)
Lead sponsor
Pusan National University Yangsan Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2026
Completion date
June 30, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

possible sarcopenia, sarcopenia